PRMT5 inhibition reduces viability and stemness of pediatric high grade glioma by Brown, EJ, Balaguer-Lluna, L, Cribbs, A, Philpott, M, Carcaboso, AM, Farnie, G, Bullock, AN

PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivo by Brown, EJ, Balaguer-Lluna, L, Cribbs, AP, Philpott, M, Campo, L, Browne, M, Wong, JF, Oppermann, U, Carcaboso, AM, Bullock, AN, Farnie, G